Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""CLINICAL trials"" wg kryterium: Temat


Starter badań:

Tytuł:
Safety and efficacy of post-haematopoietic cell transplantation maintenance therapy with blinatumomab for relapsed/refractory CD19-positive B-cell acute lymphoblastic leukaemia: protocol for a phase I-II, multicentre, non-blinded, non-controlled trial (JPLSG SCT-ALL-BLIN21).
Autorzy:
Sakaguchi H; Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan .
Umeda K; Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Kato I; Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Sakaguchi K; Department of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Hiramatsu H; Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Ishida H; Department of Pediatrics, Kyoto City Hospital, Kyoto, Japan.
Yabe H; Department of Innovative Medical Science, Tokai University School of Medicine, Isehara, Japan.
Goto H; Division of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan.
Kawahara Y; Department of Pediatrics, Jichi Medical University School of Medicine, Tochigi, Japan.
Yamashita YI; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
Sanada M; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
Deguchi T; Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.
Takahashi Y; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Saito A; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
Noma H; Department of Data Science, The Institute of Statistical Mathematics, Tokyo, Japan.
Horibe K; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
Taga T; Department of Pediatrics, Shiga University of Medical Science, Otsu, Japan.
Adachi S; Human Health Science, Kyoto University, Kyoto, Japan.
Pokaż więcej
Corporate Authors:
Transplantation and Cellular Therapy Committee of Japanese Childhood Cancer Group
Źródło:
BMJ open [BMJ Open] 2023 Apr 17; Vol. 13 (4), pp. e070051. Date of Electronic Publication: 2023 Apr 17.
Typ publikacji:
Clinical Trial Protocol; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibodies, Bispecific*/adverse effects
Antibodies, Bispecific*/therapeutic use
Antigens, CD19*/metabolism
Clinical Trials as Topic*
Hematopoietic Stem Cell Transplantation*
Maintenance Chemotherapy*/adverse effects
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/prevention & control
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/therapy
Recurrence*
Adolescent ; Child ; Humans ; Young Adult ; Biomarkers, Tumor ; CD3 Complex/metabolism ; Clinical Trials, Phase I as Topic ; Clinical Trials, Phase II as Topic ; Disease-Free Survival ; Drug Resistance, Neoplasm/drug effects ; Graft vs Host Disease/prevention & control ; Japan ; Microbiota ; Multicenter Studies as Topic ; Neoplasm, Residual/prevention & control ; Patient Selection ; Time Factors ; Treatment Outcome ; Sample Size
Czasopismo naukowe
Tytuł:
TBCRC 057: Survey about willingness to participate in cancer clinical trials during the pandemic.
Autorzy:
Smith KL; Sidney Kimmel Comprehensive Cancer Center, Women's Malignancies Disease Group, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Mead-Harvey C; Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, Arizona, USA.
Mazza GL; Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, Arizona, USA.
Shinn EH; Department of Behavioral Science, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Frank ES; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Melisko ME; Department of Medicine (Hematology/Oncology), University of California, San Francisco, California, USA.
Eaton C; Biostatistics, Epidemiology and Data Management Core, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Liu Y; Biostatistics, Epidemiology and Data Management Core, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Salamone JM; Georgetown Breast Cancer Advocates, Washington, District of Columbia, USA.
Pollastro T; University of Washington, Seattle, Washington, USA.
Spears PA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Caston NE; Division of Hematology and Oncology, University of Alabama at Birmingham (UAB), Birmingham, Alabama, USA.
Wolff AC; Sidney Kimmel Comprehensive Cancer Center, Women's Malignancies Disease Group, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Rocque GB; Division of Hematology and Oncology, University of Alabama at Birmingham (UAB), Birmingham, Alabama, USA.; Division of Gerontology, Geriatrics, and Palliative Care, University of Alabama at Birmingham (UAB), Birmingham, Alabama, USA.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2024 Mar; Vol. 13 (5), pp. e7090.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/therapy
Pandemics*
Clinical Trials as Topic*
Patient Participation*
Female ; Humans ; Anxiety/etiology ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł:
Quantifying Site Burden to Optimize Protocol Performance.
Autorzy:
Florez M; Tufts Center for the Study of Drug Development, Tufts School of Medicine, Boston, USA. .
Smith Z; Tufts Center for the Study of Drug Development, Tufts School of Medicine, Boston, USA.
Olah Z; ZS, New York, USA.
Martin M; ZS, New York, USA.
Getz K; Tufts Center for the Study of Drug Development, Tufts School of Medicine, Boston, USA.
Pokaż więcej
Źródło:
Therapeutic innovation & regulatory science [Ther Innov Regul Sci] 2024 Mar; Vol. 58 (2), pp. 347-356. Date of Electronic Publication: 2024 Jan 08.
Typ publikacji:
Journal Article
MeSH Terms:
Clinical Trials as Topic*/standards
Humans ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł:
Clinical trials: Japan's opt-out policy raises risks of adverse drug responses.
Autorzy:
Namba M
Kaneda Y
Ozaki A
Tanimoto T
Pokaż więcej
Źródło:
Nature [Nature] 2024 Feb; Vol. 626 (7998), pp. 261.
Typ publikacji:
Letter
MeSH Terms:
Drug Approval*/legislation & jurisprudence
Drug Approval*/methods
Drug-Related Side Effects and Adverse Reactions*
Health Policy*/legislation & jurisprudence
Clinical Trials as Topic*/legislation & jurisprudence
Clinical Trials as Topic*/methods
Humans ; Japan
Opinia redakcyjna
Tytuł:
Race in clinical trials in Sweden: How regulatory and medical standards in clinical research trump the post-racial discourse.
Autorzy:
Mulinari S; Department of Sociology, Lund University, Lund, Sweden.
Bredström A; Institute for Research on Migration, Ethnicity and Society (REMESO), Linköping University, Norrköping, Sweden.
Pokaż więcej
Źródło:
Sociology of health & illness [Sociol Health Illn] 2024 Feb; Vol. 46 (2), pp. 315-332. Date of Electronic Publication: 2023 Sep 12.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Ethnicity*
Racial Groups*
Clinical Trials as Topic*
Humans ; Europe ; Sweden
Czasopismo naukowe
Tytuł:
Strategies for enhancing the representation of women in clinical trials: an evidence map.
Autorzy:
Goldstein KM; Center of Innovation to Accelerate Discovery and Practice Transformation, Durham Veterans Affairs Health Care System, 508 Fulton Street, Durham, NC, 27705, USA. .; Division of General Internal Medicine, Duke University School of Medicine, 40 Duke Medicine Circle, Durham, NC, 27710, USA. .
Kung LCY; Health Management & Policy, Graduate School of Public Health, San Diego State University, 5500 Campanile Drive, San Diego, CA, 92182-4162, USA.
Dailey SA; Center of Innovation to Accelerate Discovery and Practice Transformation, Durham Veterans Affairs Health Care System, 508 Fulton Street, Durham, NC, 27705, USA.
Kroll-Desrosiers A; VA Central Western Massachusetts Healthcare System, 421 North Main Street, Leeds, MA, 01053, USA.; UMass Chan Medical School, 55 Lake Ave. N, Worcester, MA, 01655, USA.
Burke C; Department of Population Health Sciences, Duke University School of Medicine, 215 Morris Street, Durham, NC, 27701, USA.
Shepherd-Banigan M; Center of Innovation to Accelerate Discovery and Practice Transformation, Durham Veterans Affairs Health Care System, 508 Fulton Street, Durham, NC, 27705, USA.; Department of Population Health Sciences, Duke University School of Medicine, 215 Morris Street, Durham, NC, 27701, USA.; Duke-Margolis Center for Health Policy, 100 Fuqua Drive, Box 90120, Durham, NC, 27708, USA.
Lumsden R; Division of General Internal Medicine, Duke University School of Medicine, 40 Duke Medicine Circle, Durham, NC, 27710, USA.
Sims C; Center of Innovation to Accelerate Discovery and Practice Transformation, Durham Veterans Affairs Health Care System, 508 Fulton Street, Durham, NC, 27705, USA.; Duke Rheumatology Division, 40 Duke Medicine Circle Clinic 1j, Durham, NC, 27710, USA.
Schexnayder J; University of Alabama at Birmingham School of Nursing, NB545 1720 2nd, Ave S, Birmingham, AL, 35294, USA.
Patel D; Center of Innovation to Accelerate Discovery and Practice Transformation, Durham Veterans Affairs Health Care System, 508 Fulton Street, Durham, NC, 27705, USA.
Cantrell S; Duke University Medical Center Library & Archives, Duke University School of Medicine 10 Searle Drive, Durham, NC, 27710, USA.
Sheahan KL; JSI, 2733 Crystal Drive, Arlington, VA, 22202, USA.
Gierisch JM; Center of Innovation to Accelerate Discovery and Practice Transformation, Durham Veterans Affairs Health Care System, 508 Fulton Street, Durham, NC, 27705, USA.; Division of General Internal Medicine, Duke University School of Medicine, 40 Duke Medicine Circle, Durham, NC, 27710, USA.; Department of Population Health Sciences, Duke University School of Medicine, 215 Morris Street, Durham, NC, 27701, USA.
Pokaż więcej
Źródło:
Systematic reviews [Syst Rev] 2024 Jan 02; Vol. 13 (1), pp. 2. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:
Journal Article
MeSH Terms:
Clinical Trials as Topic*
Women*
Patient Selection*
Female ; Humans ; Male ; Gender Identity
Czasopismo naukowe
Tytuł:
Is the "P-value" Alone a Sufficient Metric for the Magnitude of Clinical Benefit and Which Clinical Trial Is Actually Positive, KEYNOTE-394 or KEYNOTE-240?
Autorzy:
Kus T; Department of Medical Oncology, School of Medicine, Gaziantep University, Gaziantep, Turkey.
Aktas G; Gaziantep Medical Park Private Hospital, Gaziantep, Turkey.
Cicin I; Department of Medical Oncology, School of Medicine, Trakya University, Edirne, Turkey.
Pokaż więcej
Źródło:
The oncologist [Oncologist] 2024 Mar 04; Vol. 29 (3), pp. 190-191.
Typ publikacji:
Journal Article
MeSH Terms:
Antineoplastic Combined Chemotherapy Protocols*
Clinical Trials as Topic*
Humans
Czasopismo naukowe
Tytuł:
An Overview of Current Statistical Methods for Implementing Quality Tolerance Limits.
Autorzy:
Kilaru R; PPD, Part of Thermo Fisher Scientific, 929 North Front Street, Wilmington, NC, 28401-3331, USA. .
Amodio S; Biometrics, Medical and Nutritional Science, Danone Nutricia Research, Utrecht, The Netherlands.
Li Y; Biometrics, Medical and Nutritional Science, Danone Nutricia Research, Utrecht, The Netherlands.
Wells C; Roche Products Ltd, 6 Falcon Way, Shire Park Welwyn, Garden City, AL7 1TW, UK.
Love S; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, UK.
Zeng Y; Central Statistical Monitoring (CSM), Data Science and Digital Innovations (DSDI), Global Statistical and Data Sciences (GSDS), BeiGene, Wuhan, China.
Ye J; Data Science and Digital Innovations (DSDI), Global Statistical and Data Sciences (GSDS), BeiGene, Fulton, MD, USA.
Jelizarow M; Center of Excellence for Statistical Innovation (CESI), Statistical Sciences & Innovation (SSI), UCB BIOSCIENCES GmbH, Alfred-Nobel-Strasse 10, 40789, Monheim, Germany.
Balakumar A; Health Data Insights and Design, Global Clinical Operations, Novartis Healthcare Pvt. Ltd, Hyderabad, India.
Fronc M; Central Monitoring and Data Analytics, Global Clinical Operations, GSK, Warsaw, Poland.; SGH Warsaw School of Economics, Warsaw, Poland.
Osterdal AS; ALK, Bøge Alle 1, Hørsholm, Denmark.
Rolfe T; Central Monitoring and Data Analytics, Global Clinical Operations, GSK, London, UK.
Talbot S; Amgen Inc, Thousand Oaks, CA, USA.
Pokaż więcej
Źródło:
Therapeutic innovation & regulatory science [Ther Innov Regul Sci] 2024 Mar; Vol. 58 (2), pp. 273-284. Date of Electronic Publication: 2023 Dec 26.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Clinical Trials as Topic*
Quality Control*
Humans ; Bayes Theorem
Czasopismo naukowe
Tytuł:
Training New DMC Members: A Call to Action.
Autorzy:
Rockhold F; Duke University Medical Center, Durham, USA. .; Duke Clinical Research Institute, Durham, USA. .
Mahaffey K; Stanford University Medical School, Stanford, USA.
DeMets D; Unversity of Wisconsin, Madison, USA.
Pokaż więcej
Źródło:
Therapeutic innovation & regulatory science [Ther Innov Regul Sci] 2024 Mar; Vol. 58 (2), pp. 234-235. Date of Electronic Publication: 2023 Sep 25.
Typ publikacji:
Journal Article
MeSH Terms:
Clinical Trials Data Monitoring Committees*
Mentoring*
Industry ; Inservice Training ; Humans
Czasopismo naukowe
Tytuł:
Evaluating a shrinkage estimator for the treatment effect in clinical trials.
Autorzy:
van Zwet EW; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.
Tian L; Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, California, USA.
Tibshirani R; Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, California, USA.; Department of Statistics, Stanford University, Stanford, California, USA.
Pokaż więcej
Źródło:
Statistics in medicine [Stat Med] 2024 Feb 28; Vol. 43 (5), pp. 855-868. Date of Electronic Publication: 2023 Dec 19.
Typ publikacji:
Journal Article
MeSH Terms:
Clinical Trials as Topic*
Humans ; Bias ; Systematic Reviews as Topic ; Meta-Analysis as Topic
Czasopismo naukowe
Tytuł:
Legacy lessons from the COVID-19 era to improve trial participation and retention: Views from trial participants, PPIE contributors and trial staff across the NIHR portfolio.
Autorzy:
Leggett H; York Trials Unit, The University of York, York, United Kingdom.
Vinall-Collier K; School of Dentistry, The University of Leeds, Leeds, United Kingdom.
Csikar J; School of Dentistry, The University of Leeds, Leeds, United Kingdom.
Barber S; School of Dentistry, The University of Leeds, Leeds, United Kingdom.
Carr R; York Trials Unit, The University of York, York, United Kingdom.
Bhatti A; School of Dentistry, The University of Leeds, Leeds, United Kingdom.
Pavitt S; School of Dentistry, The University of Leeds, Leeds, United Kingdom.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Feb 21; Vol. 19 (2), pp. e0296343. Date of Electronic Publication: 2024 Feb 21 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Clinical Trials as Topic*
COVID-19*/epidemiology
Aged ; Humans ; Communication ; Focus Groups ; Pandemics ; Trust
Czasopismo naukowe
Tytuł:
Group sequential designs for pragmatic clinical trials with early outcomes: methods and guidance for planning and implementation.
Autorzy:
Parsons NR; Warwick Clinical Trials Unit (WCTU), Warwick Medical School, University of Warwick, CV4 7AL, Coventry, UK. .
Basu J; Warwick Clinical Trials Unit (WCTU), Warwick Medical School, University of Warwick, CV4 7AL, Coventry, UK.
Stallard N; Warwick Clinical Trials Unit (WCTU), Warwick Medical School, University of Warwick, CV4 7AL, Coventry, UK.
Pokaż więcej
Źródło:
BMC medical research methodology [BMC Med Res Methodol] 2024 Feb 16; Vol. 24 (1), pp. 42. Date of Electronic Publication: 2024 Feb 16.
Typ publikacji:
Journal Article
MeSH Terms:
Research Design*
Pragmatic Clinical Trials as Topic*
Humans ; Computer Simulation
Czasopismo naukowe
Tytuł:
Review of brachytherapy clinical trials: a cross-sectional analysis of ClinicalTrials.gov.
Autorzy:
Chen D; Princess Margaret Cancer Centre, Radiation Medicine Program, Toronto, ON, Canada.; Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Parsa R; Princess Margaret Cancer Centre, Radiation Medicine Program, Toronto, ON, Canada.; Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada.
Chauhan K; Princess Margaret Cancer Centre, Radiation Medicine Program, Toronto, ON, Canada.
Lukovic J; Princess Margaret Cancer Centre, Radiation Medicine Program, Toronto, ON, Canada.; Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada.
Han K; Princess Margaret Cancer Centre, Radiation Medicine Program, Toronto, ON, Canada.; Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada.
Taggar A; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Raman S; Princess Margaret Cancer Centre, Radiation Medicine Program, Toronto, ON, Canada. .; Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada. .; Department of Radiation Oncology, Princess Margaret Cancer Centre, 610 University Avenue, Toronto, ON, M5G 2M9, Canada. .
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2024 Feb 13; Vol. 19 (1), pp. 22. Date of Electronic Publication: 2024 Feb 13.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Brachytherapy*
Clinical Trials as Topic*
Female ; Humans ; Male ; Cross-Sectional Studies
Czasopismo naukowe
Tytuł:
Good Statistical Practice-development of tailored Good Clinical Practice training for statisticians.
Autorzy:
Stocken DD; Leeds Institute of Clinical Trials Research, Faculty of Medicine and Health, University of Leeds, Leeds, UK. .
Mossop H; Biostatistics Research Group, Institute of Health and Society, Newcastle University, Newcastle Upon Tyne, UK.
Armstrong E; Leeds Institute of Clinical Trials Research, Faculty of Medicine and Health, University of Leeds, Leeds, UK.
Lewis S; Edinburgh Clinical Trials Unit, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK.
Dutton SJ; Oxford Clinical Trials Research Unit, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
Peckitt C; Royal Marsden and Institute for Cancer Research Clinical Trials Units, The Royal Marsden NHS Foundation Trust, London, UK.
Gamble C; Liverpool Clinical Trials Clinical Trials Research Centre, Department of Biostatistics, University of Liverpool, Liverpool, UK.
Brown J; Leeds Institute of Clinical Trials Research, Faculty of Medicine and Health, University of Leeds, Leeds, UK.
Pokaż więcej
Źródło:
Trials [Trials] 2024 Feb 10; Vol. 25 (1), pp. 113. Date of Electronic Publication: 2024 Feb 10.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Statistics as Topic*/standards
Clinical Trials as Topic*
Humans ; Reproducibility of Results
Czasopismo naukowe
Tytuł:
Strategies for secondary use of real-world clinical and administrative data for outcome ascertainment in pragmatic clinical trials.
Autorzy:
Hau C; Cooperative Studies Program Coordinating Center, VA Boston Healthcare System, Boston, MA, United States. Electronic address: .
Woods PA; Cooperative Studies Program Coordinating Center, VA Boston Healthcare System, Boston, MA, United States.
Guski AS; Cooperative Studies Program Coordinating Center, VA Boston Healthcare System, Boston, MA, United States.
Raju SI; Minneapolis VA Healthcare System, Minneapolis, MN, United States.
Zhu L; Cooperative Studies Program Coordinating Center, VA Boston Healthcare System, Boston, MA, United States.
Alba PR; VA Informatics and Computing Infrastructure, Salt Lake City VA Healthcare System, Salt Lake City, CT, United States; Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, United States.
Cushman WC; Medical Service, Memphis VA Medical Center, Memphis, TN, United States; Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis, TN, United States.
Glassman PA; Pharmacy Benefits Management Services, Department of Veterans Affairs, Washington DC, United States; VA Greater Los Angeles Healthcare System, Los Angeles, CA, United States; David Geffen School of Medicine at UCLA, Los Angeles, CA, United States.
Ishani A; Minneapolis VA Healthcare System, Minneapolis, MN, United States; Department of Medicine, University of Minnesota, Minneapolis, MN, United States.
Taylor AA; Michael E. DeBakey VA Medical Center, Houston, TX, United States; Baylor College of Medicine, Department of Medicine, Houston, TX, United States.
Ferguson RE; Cooperative Studies Program Coordinating Center, VA Boston Healthcare System, Boston, MA, United States; Department of Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States.
Leatherman SM; Cooperative Studies Program Coordinating Center, VA Boston Healthcare System, Boston, MA, United States; Department of Biostatistics, Boston University School of Public Health, Boston, MA, United States.
Pokaż więcej
Źródło:
Journal of biomedical informatics [J Biomed Inform] 2024 Feb; Vol. 150, pp. 104587. Date of Electronic Publication: 2024 Jan 18.
Typ publikacji:
Journal Article
MeSH Terms:
Pragmatic Clinical Trials as Topic*
Aged ; Humans ; Medicare ; Treatment Outcome ; United States
Czasopismo naukowe
Tytuł:
The future of the global clinical trial ecosystem: a vision from the first WHO Global Clinical Trials Forum.
Autorzy:
Moorthy V; Science Division, World Health Organization, 1211 Geneva, Switzerland. Electronic address: .
Abubakar I; University College London, London, UK.
Qadri F; icddr,b (International Centre for Diarrhoeal Disease Research), Dhaka, Bangladesh.
Ogutu B; Kenya Medical Research Institute (KEMRI), Nairobi, Kenya.
Zhang W; Science Division, World Health Organization, 1211 Geneva, Switzerland.
Reeder J; Science Division, World Health Organization, 1211 Geneva, Switzerland.
Farrar J; Science Division, World Health Organization, 1211 Geneva, Switzerland.
Pokaż więcej
Źródło:
Lancet (London, England) [Lancet] 2024 Jan 13; Vol. 403 (10422), pp. 124-126. Date of Electronic Publication: 2023 Dec 18.
Typ publikacji:
Journal Article
MeSH Terms:
Clinical Trials as Topic*
Humans ; World Health Organization
Czasopismo naukowe
Tytuł:
Constructing a finer-grained representation of clinical trial results from ClinicalTrials.gov.
Autorzy:
Shi X; Institute of Medical Technology, Peking University, Beijing, 100191, China.; National Institute of Health Data Science, Peking University, Beijing, 100191, China.
Du J; Institute of Medical Technology, Peking University, Beijing, 100191, China. .; National Institute of Health Data Science, Peking University, Beijing, 100191, China. .
Pokaż więcej
Źródło:
Scientific data [Sci Data] 2024 Jan 06; Vol. 11 (1), pp. 41. Date of Electronic Publication: 2024 Jan 06.
Typ publikacji:
Dataset; Journal Article
MeSH Terms:
Clinical Trials as Topic*
Humans ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Sponsorship of Clinical Trials Related to the Shoulder and Elbow: Trends Over Time and Comparative Analysis of Trial Characteristics by Sponsorship Type.
Autorzy:
Caruana DL; From the Department of Orthopaedics and Rehabilitation, Yale School of Medicine, New Haven, CT.
Grauer JN
Pokaż więcej
Źródło:
Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews [J Am Acad Orthop Surg Glob Res Rev] 2024 Jan 02; Vol. 8 (1). Date of Electronic Publication: 2024 Jan 02 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Elbow*
Elbow Joint*
Shoulder*
Clinical Trials as Topic*
Government Agencies ; Health Facilities ; Humans
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies